Faculty Opinions recommendation of The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

C. Proud,Jianling Xie,Xuemin Wang

Published 2016 in Unknown venue

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2016
Venue
Unknown venue
Publication date
2016-08-18
Fields of study
Medicine
Identifiers
DOI 10.3410/F.721619280.793522105
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

No citing papers are available for this paper.